Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study-Reference-Cited by-同舟云学术

Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study

Published:2020-09 Issue: Volume:159 Page:104965
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Russo Vincenzo,Di Maio Marco,Attena Emilio,Silverio Angelo,Scudiero Fernando,Celentani Dario,Lodigiani Corrado,Di Micco Pierpaolo

Publisher

Elsevier BV

Subject

Pharmacology

Reference12 articles.

1. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China;Hui;Int. J. Infect. Dis.,2020

2. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area;Richardson;JAMA,2020

3. COVID-19 cytokine storm: the interplay between inflammation and coagulation;Jose;Lancet Respir Med,2020

4. ARDS definition task force. Acute respiratory distress syndrome: the Berlin definition;Ranieri;JAMA,2012

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombotic Therapy in Arterial Thrombosis and Thromboembolism in COVID-19;CHEST;2023-12

2. The Role of Anticoagulants and Antiplatelets in Reducing Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis of Studies Reporting Adjusted Data;Cureus;2023-09-22

3. A systematic review and meta-analysis on the prevalence and impact of coronary artery disease in hospitalized COVID-19 patients;Heliyon;2023-09

4. Therapeutic Approaches for Intravascular Microthrombi-induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Infection;Current Pharmaceutical Biotechnology;2023-07

5. Anticoagulant therapy in COVID‐19: A narrative review;Clinical and Translational Science;2023-06-30